First Report Managed Care
@FirstReportMC
Followers
746
Following
141
Statuses
11K
Your Go-To Resource for the Latest Developments in the Rapidly Changing Sector of Managed Care @PopHealthNet Email: [email protected]
Malvern PA
Joined November 2009
Study authors examined the safety and effectiveness of pitolisant in #patients with type I narcolepsy who did not tolerate or respond to previous treatments.
0
0
0
There's still time to register for the managed care considerations webinar on Addressing the Burdens of Alzheimer's Disease. Check out the two dates and times below!
0
0
0
Researchers assessed potential factors driving differences in #disease burden between African American and White patients with multiple sclerosis.
0
0
0
Patients with relapsing/remitting multiple sclerosis reported improvements in #medication satisfaction, fatigue, and other measures after switching from other therapies to a monoclonal antibody.
0
0
0
Happening soon! There's still time to register for today's webinar on managed care considerations for the treatment of tardive dyskinesia. Can't make it? Check out the other date below!
0
0
0
In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating #patients with zanubrutinib.
0
0
1
#ICYMI There is still time to register for tomorrow's Managed Care Considerations webinar happening at 1 p.m.
0
0
0
In addition to the #Economic burden of the disease, researchers also reported the humanistic burden associated with pediatric-onset multiple sclerosis.
0
0
0
Between 2012 and 2017, pediatric hospitalizations for atopic dermatitis predominantly involved children covered by #PublicHealth plans, findings show.
0
0
0
Study authors examined comorbidities and potential extaneural manifestations associated with spinal muscular atrophy in treatment-naive patients.
0
0
0
Researchers examined the impact of #medication and symptom control on real-world quality of life in patients with #narcolepsy during 5 years of follow-up.
0
0
0
Study authors examined the efficacy and safety of a 24-week regimen of CTP-543 in #patients with chronic, moderate-to-severe alopecia areata.
0
0
0
In this commentary, Steven McNeilly offers insight into a health system's approach to value-based #care including advice for improving metrics and relationships with payers and providers.
0
0
0
The Centers for Medicare & Medicaid Services and the US Department of Health and Human Services are expanding access to #dentalcare, #cancer screening coverage, and behavioral health #care
0
0
0
“Availability of lower cost therapies may considerably decrease the #economic burden on these patients and the #healthcare systems,” wrote researchers.
0
0
0
Gary Owens, MD, president, Gary Owens Associates, describes the current #treatment landscape for spinal muscular atrophy and the #challenges payers face when covering this patient population.
0
0
0
Using claims data from #MedicareAdvantage, Managed Medicaid, and commercial insurance plans, researchers identified the #costs associated with severe, persistent #asthma.
0
0
0
“Coverage appears to be more likely for prescription-only digital therapeutics; however, challenges with proof of long-term benefit, patient adherence, and fulfillment remain,” said authors of a poster presented at #AMCPNexus 2022.
0
0
0
Researchers determined the association between #insurance type and #HIV outcomes, including antiretroviral adherence and health-related quality of life.
0
1
0
Check out the latest issue which features content on #diabetes prevention, #cannabis and #psychedelics gaining clinical acceptance, the latest industry updates, and more.
0
0
2